Divi’s Laboratories has announced a board meeting scheduled for November 07, 2025, to review and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025 (Q2 FY26). The company also stated that the trading window, which was closed on October 01, 2025, will remain closed until November 09, 2025.
Board Meeting for Q2 FY26 Results
A meeting of the Board of Directors of Divi’s Laboratories is scheduled for November 07, 2025. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year which concluded on September 30, 2025 (Q2 FY26).
Trading Window Closure
The company has announced that the trading window, initially closed on September 30, 2025, for dealing in the company’s securities, remains closed from October 01, 2025. This closure will extend until 48 hours after the declaration of the financial results. Therefore, the trading window will remain closed until November 09, 2025.
Source: BSE
